Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited disclaim responsibility for the contents of Starcoin Group Limited’s announcement dated 19 January 2026 and disclaim any liability for losses arising from reliance upon any part of its content. Starcoin Group Limited, formerly known as Innovative Pharmaceutical Biotech Limited, confirmed that its principal place of business in Hong Kong will change with effect from 19 January 2026.

The new address is 21/F, Henley Building, 5 Queen's Road Central, Central, Hong Kong. The telephone number will be (852) 2598 6638, and the facsimile number remains unchanged. According to the announcement signed by Chairman Dr. Yeung Yung, the board of directors currently comprises Dr. Yeung Yung, Mr. Gao Yuan Xing, Mr. Tang Rong, Ms. Qi Shujuan, Dr. Long Fan, Dr. Wu Ming, and Mr. Zhang Shen as executive directors; Mr. Zhang Yi as non-executive director; and Ms. Chen Weijun, Mr. Wang Rongliang, Mr. Chen Jinzhong, Dr. Xia Tingkang Tim, and Ms. Sun Sizheng as independent non-executive directors.

Further details are available on the company’s websites, www.starcoingroup.com and www.irasia.com/listco/hk/starcoingroup.